Who founded Nanitebio?

Nanitebio was founded by Shashi Murthy, Sean Kevlahan, Thomas Neenan in 2020.

Who are Nanitebio's investors?

Nanitebio's investors include Bantam Group, Civilization Ventures Management, Llc.

How much funding has Nanitebio raised?

Nanitebio has disclosed $4.1M raised across 1 round.

Where is Nanitebio headquartered?

Nanitebio is headquartered in Boston, US.

Nanitebio

Boston, US · Founded 2020 · 15 employees on LinkedIn · 2 known investors

Find your way into Nanitebio

161 people in our graph share verified history with the Nanitebio team — schools, employers, funds. One of them is your warm intro.

Anika Guptaunlockedknows Shashi Murthy · together at Broad Institute (overlapped)

×7knows the team · via Broad Institute

×4knows the team · via Boston Children's Hospital

Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy. It targets subcutaneous gene therapy as an alternative to viral vectors and lipid nanoparticles.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Nanitebio was founded in 2020 by Shashi Murthy, Sean Kevlahan, and Thomas Neenan.

Shashi Murthy inCo-Founder & Chief Technology Officer2022–2025Shashi Murthy is an executive officer at Nanitebio, which develops resorbable polymer nanoparticles for non-viral genetic drug delivery. He has previously founded and served as CTO of multiple acquired startups.

Sean KevlahaninChief Executive Officer and Co-Founder

Thomas NeenaninCo-founder & CBO

Investors · 2

Bantam GroupWestwood

Civilization Ventures Management, LlcTiburon · $1M – $10M

Reported raises · per SEC filings

Form D private placements

$4.1M disclosed across 1 round · 2022

▶$4.1MraisedMay 2022 · 11 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Shashi MurthyExecutive Officer
Sean KevlahanExecutive Officer, Director, Promoter
Thomas X. NeenanExecutive Officer

Offering amount: $6.1M
Amount sold: $4.1M
First sale: May 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Nanobiotix5 shared keywordsNanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.

Companies competing with Nanitebio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Nanitebio do?: Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy. It targets subcutaneous gene therapy as an alternative to viral vectors and lipid nanoparticles.
Who founded Nanitebio?: Nanitebio was founded by Shashi Murthy, Sean Kevlahan, Thomas Neenan in 2020.
Who are Nanitebio's investors?: Nanitebio's investors include Bantam Group, Civilization Ventures Management, Llc.
How much funding has Nanitebio raised?: Nanitebio has disclosed $4.1M raised across 1 round.
Where is Nanitebio headquartered?: Nanitebio is headquartered in Boston, US.